3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
8
Carcinoma, Non-Small-Cell Lung
7
Pancreatic Neoplasms
6
Colorectal Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Renal Cell
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Neoplasms
4
Nasopharyngeal Carcinoma
4
Triple Negative Breast Neoplasms
3
Neoplasm Metastasis
3
Esophageal Squamous Cell Carcinoma
3
Endometrial Neoplasms
3
Skin Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Glioblastoma
2
Advanced Solid Tumors
2
von Hippel-Lindau Disease
1
Thyroid cancer, follicular
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Adenocarcinoma
1
Solid Tumors
1
Solid Tumor, Adult
1
Solid Tumor
1
Interventions
pembrolizumab
44
Gemcitabine
23
Nivolumab
21
enfortumab vedotin
20
Cisplatin
17
avelumab
16
Magnetic Resonance Spectroscopy
16
Carboplatin
14
atezolizumab
13
Specimen Handling
12
Docetaxel
11
sacituzumab govitecan
9
Paclitaxel
8
Ipilimumab
8
durvalumab
6
Mitomycin
5
Fluorodeoxyglucose F18
5
cabozantinib
4
Taxes
4
toripalimab
3
pemigatinib
3
erdafitinib
3
X-Rays
3
Radiosurgery
3
Platinum
3
Pemetrexed
3
Immunoglobulin G
3
CTLA-4 Antigen
3
Biopsy
3
ALT-803
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
spartalizumab
×
1 year
×
Clear all
No trials found.